Physician profile
Harvey R Chen
NPI 1144245374
$25,287.80
in general payments reported to CMS, 2019-2025
36 companies · $3,205 in 2025
The $3,205 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,987 · 2020: $1,843 · 2021: $2,021 · 2022: $4,335 · 2023: $3,839 · 2024: $4,058 · 2025: $3,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,012 · Travel and Lodging: $4,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,012.13 |
| Travel and Lodging | $4,089.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,112.98 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Ensite Precision |
| Medical Device Business Services, INC. | $4,561.97 | 2019-2024 | Carto 3 |
| Boston Scientific Corporation | $4,540.38 | 2019-2025 | Vigilant X4 Crt-D, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $4,373.49 | 2019-2025 | Carto 3 |
| Medtronic Vascular, INC. | $3,352.40 | 2019-2020 | |
| Medtronic, INC. | $663.85 | 2021-2025 | Corevalve Evolut R, Abre, Na |
| Impulse Dynamics (USA) INC. | $458.93 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.10 | 2019-2025 | Lifevest |
| Biotronik INC. | $184.96 | 2019-2022 | |
| Inari Medical, INC. | $182.18 | 2022 | |
| Abiomed | $177.76 | 2023 | Impella |
| Penumbra, INC. | $159.79 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $139.10 | 2024-2025 | |
| Shockwave Medical, INC | $128.30 | 2025 | |
| W. L. Gore & Associates, INC. | $123.63 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $120.71 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.75 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $75.26 | 2019-2024 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $74.43 | 2021 | |
| Cleerly, INC. | $71.69 | 2025 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $54.46 | 2023-2024 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $49.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.23 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $36.41 | 2020-2023 | Farxiga |
| Bard Peripheral Vascular, INC. | $34.75 | 2025 | Rotarexs 6 F X 135 Cm |
| Atricure, INC. | $30.80 | 2024 | |
| Edwards Lifesciences Corporation | $29.82 | 2023 | |
| Angiodynamics, INC. | $24.79 | 2022 | |
| Cardiovascular Systems INC. | $21.45 | 2021 | |
| Amarin Pharma, INC. | $20.98 | 2019 | |
| Novo Nordisk INC | $18.78 | 2024 | Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $18.35 | 2024 | Arcalyst |
| Pfizer INC. | $18.08 | 2024 | |
| Inspire Medical Systems, INC. | $17.74 | 2024 | Inspire |
| Teleflex LLC | $17.53 | 2025 | Orsiro Mission |
| Ethicon US, LLC | $15.20 | 2025 | Surgiflo Hemostatic Matrix, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.